My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 218

    1.

    Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.

    Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA.

    Ann Intern Med. 1997 Jan 1;126(1):1-12.PMID: 8992917 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.

    Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA.

    Am Heart J. 2002 Sep;144(3):440-8.PMID: 12228780 [PubMed - indexed for MEDLINE]Related articles

    3.

    Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

    Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK.

    Ann Intern Med. 2001 Nov 20;135(10):870-83.PMID: 11712877 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

    Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cost-effectiveness of implantable cardioverter-defibrillators.

    Sanders GD, Hlatky MA, Owens DK.

    N Engl J Med. 2005 Oct 6;353(14):1471-80.PMID: 16207849 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review.

    Parkes J, Bryant J, Milne R.

    Health Technol Assess. 2000;4(26):1-69. Review.PMID: 11086270 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.

    Spath MA, O'Brien BJ.

    Pharmacoeconomics. 2002;20(11):727-38. Review.PMID: 12201792 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.

    Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W.

    Ann Noninvasive Electrocardiol. 2005 Oct;10(4 Suppl):67-83.PMID: 16274418 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy.

    Larsen GC, Manolis AS, Sonnenberg FA, Beshansky JR, Estes NA, Pauker SG.

    J Am Coll Cardiol. 1992 May;19(6):1323-34.PMID: 1564234 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone.

    Caro JJ, Ward A, Deniz HB, O'Brien JA, Ehreth JL.

    Value Health. 2007 Jan-Feb;10(1):13-22.PMID: 17261112 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis.

    O'Brien BJ, Buxton MJ, Rushby JA.

    Br Heart J. 1992 Aug;68(2):241-5.PMID: 1389748 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.

    J Am Coll Cardiol. 2006 Jul 4;48(1):112-21. Epub 2006 Jun 9.PMID: 16814657 [PubMed - indexed for MEDLINE]Related articles

    13.

    Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.

    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.

    Am Heart J. 2007 Nov;154(5):899-907.PMID: 17967596 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators.

    Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.PMID: 16818817 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

    Neyt M, Thiry N, Ramaekers D, Van Brabandt H.

    Appl Health Econ Health Policy. 2008;6(1):67-80.PMID: 18774871 [PubMed - indexed for MEDLINE]Related articles

    16.

    The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.

    Eur Heart J. 2007 Jan;28(1):42-51. Epub 2006 Nov 16.PMID: 17110403 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure.

    Chen L, Hay JW.

    Cardiovasc Drugs Ther. 2004 Mar;18(2):161-70.PMID: 15162078 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator.

    Kupersmith J, Hogan A, Guerrero P, Gardiner J, Mellits ED, Baumgardner R, Rovner D, Holmes-Rovner M, McLane A, Levine J, et al.

    Am Heart J. 1995 Sep;130(3 Pt 1):507-15.PMID: 7661068 [PubMed - indexed for MEDLINE]Related articles

    19.

    New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

    Klein H, Auricchio A, Reek S, Geller C.

    Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.PMID: 10089848 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.

    Wever EF, Hauer RN, Schrijvers G, van Capelle FJ, Tijssen JG, Crijns HJ, Algra A, Ramanna H, Bakker PF, Robles de Medina EO.

    Circulation. 1996 Feb 1;93(3):489-96.PMID: 8565166 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity